2-26482516-G-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_194248.3(OTOF):āc.1469C>Gā(p.Pro490Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,613,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 33)
Exomes š: 0.000026 ( 0 hom. )
Consequence
OTOF
NM_194248.3 missense
NM_194248.3 missense
Scores
11
6
2
Clinical Significance
Conservation
PhyloP100: 9.94
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.906
PP5
Variant 2-26482516-G-C is Pathogenic according to our data. Variant chr2-26482516-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 48170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.1469C>G | p.Pro490Arg | missense_variant | 14/47 | ENST00000272371.7 | NP_919224.1 | |
OTOF | NM_001287489.2 | c.1469C>G | p.Pro490Arg | missense_variant | 14/46 | NP_001274418.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.1469C>G | p.Pro490Arg | missense_variant | 14/47 | 1 | NM_194248.3 | ENSP00000272371.2 | ||
OTOF | ENST00000403946.7 | c.1469C>G | p.Pro490Arg | missense_variant | 14/46 | 5 | ENSP00000385255.3 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
152244
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250848Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135820
GnomAD3 exomes
AF:
AC:
5
AN:
250848
Hom.:
AF XY:
AC XY:
3
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460814Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 726696
GnomAD4 exome
AF:
AC:
38
AN:
1460814
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
726696
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
GnomAD4 genome
AF:
AC:
5
AN:
152244
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2024 | Observed with a second OTOF variant in unrelated patients with hearing loss in published literature (PMID: 33426078, 33908410); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 37677959, 33426078, 33908410, 27652356, 34424407) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2023 | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 490 of the OTOF protein (p.Pro490Arg). This variant is present in population databases (rs80356585, gnomAD 0.004%). This missense change has been observed in individuals with auditory neuropathy spectrum disorder and/or deafness (PMID: 27652356, 33426078, 33908410, 34424407). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 48170). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on OTOF protein function. For these reasons, this variant has been classified as Pathogenic. - |
OTOF-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 05, 2024 | The OTOF c.1469C>G variant is predicted to result in the amino acid substitution p.Pro490Arg. This variant has been reported in the homozygous or compound heterozygous state in individuals with auditory neuropathy (Al-Wardy et al. 2016. PubMed ID: 27652356; Zhai et al. 2020. PubMed ID: 33426078; Table S1A, Thorpe et al. 2021. PubMed ID: 34424407). Of note, another variant impacting the same amino acid (p.Pro490Gln) was reported in cis with another variant in OTOF (p.Ile515Thr), both in the homozygous state in four individuals from the same family, all with nonsyndromic autosomal recessive deafness (Mirghomizadeh et al. 2002. PubMed ID: 12127154). This variant is reported in 0.0044% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Nonsyndromic genetic hearing loss Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 16, 2023 | Variant summary: OTOF c.1469C>G (p.Pro490Arg) results in a non-conservative amino acid change located in the C2 domain (IPR000008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 250848 control chromosomes (gnomAD). c.1469C>G has been reported in the literature as a biallelic genotype in multiple individuals affected with Nonsyndromic Hearing Loss And Deafness, including at least one family in which it segregated with the disease phenotype (e.g. Al-Wardy_2016, Zhai_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not specified Uncertain:1
Uncertain significance, flagged submission | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 21, 2011 | Variant classified as Uncertain Significance - Favor Pathogenic. The Pro490Arg i n OTOF variant has not been reported in the literature nor previously reported i n the laboratory. This residue is conserved across species and computational ana lyses (biochemical amino acid properties, homology, PolyPhen2, SIFT) suggest tha t the Pro490Arg variant may impact the protein. However, this information is not predictive enough to assume pathogenicity. Another variant at the same codon (P ro490Gln) has been reported in one Turkish family with profound hearing loss; ho wever, this variant was observed in cis with a second OTOF missense variant of u nknown significance in that family (Mighomizadeh 2002). The presence of this var iant in combination with a reported pathogenic variant and in this individual wh o has auditory neuropathy, increases the likelihood that the Pro490Arg variant i s pathogenic. In summary, the clinical significance of this variant cannot be de termined at this time; however, based upon the arguments described above, we wou ld lean towards a more likely pathogenic role. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0014);Gain of MoRF binding (P = 0.0014);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at